Reviewing the recent developments in idiopathic intracranial hypertension

J Virdee, S Larcombe, Vivek Vijay, Alex Sinclair, M Dayan, Susan Mollan

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
171 Downloads (Pure)


There is increasing evidence and appreciation of idiopathic intracranial hypertension (IIH) in medicine. The pathological processes underlying raised intracranial pressure are being studied, with new insights found in both hormonal dysregulation and the metabolic neuroendocrine axis. These will potentially lead to novel therapeutic targets for IIH. The first consensus guidelines have been published on the investigation and management of adult IIH, and the International Headache Society criteria for headache attributable to IIH have been modified to reflect our evolving understanding of IIH. Randomized clinical trials have been published, and a number of studies in this disease area are ongoing.
Original languageEnglish
Pages (from-to)767-781
JournalOphthalmology and Therapy
Issue number4
Early online date9 Sept 2020
Publication statusE-pub ahead of print - 9 Sept 2020


  • Headache
  • ICP
  • Idiopathic intracranial
  • Lumbar puncture
  • Obesity
  • Papilloedema
  • Pseudotumour cerebri
  • Raised
  • Weight management
  • hypertension


Dive into the research topics of 'Reviewing the recent developments in idiopathic intracranial hypertension'. Together they form a unique fingerprint.

Cite this